HHS Aims To Reduce Prescription Drug Costs Through 3 New Models
The U.S. Department of Health & Human Services announced three models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models, which include access to $2 generic drugs, build on the Inflation Reduction Act of 2022.
United States Xavier Becerra Joe Biden Innovation Center Drug Administration Us Department Of Health Human Services
Source: medcitynews.com